| Literature DB >> 21572734 |
Laila Hassan Mohamad Elshazly1.
Abstract
PURPOSE: This study was aimed at to determine the frequency of excised conjunctival lesions in a patient population treated over a 10-year period.Entities:
Keywords: Conjunctiva; Hemangioma; Nevus; Ocular Surface Squamous Neoplasia; Papilloma
Year: 2011 PMID: 21572734 PMCID: PMC3085152 DOI: 10.4103/0974-9233.75886
Source DB: PubMed Journal: Middle East Afr J Ophthalmol ISSN: 0974-9233
Distribution of excised conjunctival lesions in relation to the age and sex of the cohort
| Number (%) | Age (years) (Mean + SD) | Sex male (%):female (%) | |
|---|---|---|---|
| Pyogenic granuloma | 59 (30.7) | 30.99 ± 17.2 | 34 (57.6):25 (42.4) |
| Nevus | 44 (22.9) | 19.48 ± 10.57 | 21 (47.7):23 (52.3) |
| Cyst | 23 (12) | 28.26 ± 16.57 | 13 (56.5):10 (43.5) |
| OSSN | 21 (10.9) | 45.9 ± 16.7 | 9 (40.9):12 (54.5) |
| Hemangioma | 15 (7.8) | 16.8 + 9.15 | 9 (60):6 (40) |
| Papilloma | 10 (5.2) | 25.9 ± 21.1 | 5 (50):5 (50) |
| Dermolipoma | 8 (4.2) | 18.63 ± 8.16 | 4 (50):4 (50) |
| Solid dermoid | 3 (1.6) | 5.0 ± 1.5 | 2:1 |
| BLH | 4 (2.1) | 19.75 ± 7.59 | 3:1 |
| Nonspecific inflammation | 4 (2.1) | 28.25 ± 19.55 | 3:1 |
| Herniated orbital fat | 1 (0.5) | 30 | 0:1 |
| Total | 192 | 27.07 ± 17.02 | 106 (55.2):86 |
| (44.8) | |||
| 0.0001 | 0.149 |
OSSN - Ocular surface squamous neoplasia; BLH - benign lymphoid hyperplasia
Significant at P < 0.05 (ANOVA),
Chi test
P values of the t-test of the differences in mean age between conjunctival lesions
| Disease | Pyogenic granuloma | Nevus | Cystic | OSSN | Hemangioma | Papilloma | Dermolipoma | Solid dermoid |
|---|---|---|---|---|---|---|---|---|
| Pyogenic granuloma | - | 0.0001 | 0.516 | 0.001 | 0.003 | 0.41 | 0.05 | 0.0001 |
| Nevus | 0.0001 | - | 0.01 | 0.0001 | 0.019 | 0.19 | 0.169 | 0.023 |
| Cystic | 0.516 | 0.013 | - | 0.001 | 0.02 | 0.732 | 0.128 | 0.025 |
| OSSN | 0.001 | 0.0001 | 0.001 | - | 0.0001 | 0.008 | 0.0001 | 0.0001 |
| Hemangioma | 0.003 | 0.019 | 0.0001 | - | 0.056 | 0.642 | 0.045 | |
| Papilloma | 0.41 | 0.19 | 0.732 | 0.008 | 0.056 | - | 0.373 | 0.125 |
| Dermolipoma | 0.05 | 0.169 | 0.128 | 0.0001 | 0.642 | 0.373 | - | 0.021 |
| Solid dermoid | 0.0001 | 0.023 | 0.025 | 0.0001 | 0.045 | 0.125 | 0.021 | - |
| Lymphoid hyperplasia | 0.20 | 0.96 | 0.329 | 0.006 | 0.563 | 0.588 | 0.823 | 0.023 |
OSSN - Ocular surface squamous neoplasia
Significant difference of the age between lesions with the t-test (P < 0.05)
Figure 1A case of pedunculated pyogenic granuloma with a lobulated surface involving the palpebral conjunctiva after previous chalazion excision (A). Histopathologically, it had dilated and congested capillaries separated by fibrotic stroma with inflammatory cells infiltration (H and E, ×25) (B)
Figure 2A case of compound nevus involving the bulbar conjunctiva (A). Nevus cells with junctional activity in the epidermodermal junction and the dermis with excessive chronic inflammatory cells infiltration (H and E, ×100) (B). Photomicrographs of; cystic nevus (C), junctional nevus with nevus cells at the epidermodermal junction (D) (C, D H and E, ×25)
Figure 3A retention cyst occupying the temporal fornix (A). Photomicrograph showed the cubical cell layer lining of the cyst with area of epithelium rich in goblet cells (H and E, ×25) (B)
Figure 4Well-defined limbal OSSN encroaching over the cornea with gelatinous surface (A). Replacement of conjunctival epithelium by dysplastic squamous cells, thickening, and keratinization of superficial cells (atypia) (B). Sudden transition between normal and dysplastic area (arrow) with intact basement membrane (C). (B and C) H and E, ×25)
Distribution of conjunctival lesions according to site and age
| Site | Number (%) | Age(mean ± SD) |
|---|---|---|
| Limbal | 41 (21.4) | 35.927 ± 20.34 |
| Bulbar | 82 (42.7) | 22.798 ± 14.12 |
| Palpebral | 30 (15.6) | 30.4 ± 14.86 |
| Caruncle | 16 (8.3) | 25.125 ± 19.24 |
| Fornix | 11 (5.7) | 22.727 ± 10.98 |
| Punctum | 3 (1.6) | 45.33 ± 28.59 |
| Outer canthus | 9 (4.7) | 17.11 ± 8.88 |
| Total | 192 | 27.07 ± 17.021 |
| 0.0001 | 0.0001 |
Significant (Chi-test),
Significant (ANOVA)
Lesion characteristics, frequency, and demographics of previous published studies in the United States2, Iran7, and India3
| Shield | Amoli | Mondal | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Age | Sex M(%):F(%) | Site | Age | Sex M:F | Age | SexM:F | Site | ||||
| Choristoma | 40 (2) | 26 | 15 (38): 25 (62) | Bulbar | 25 (5.6) | 11 | - | ||||
| Benign | |||||||||||
| Epithelial (papillomas) | 38 (2) | 46 | 30 (79): 8 (21%) | Limbal | 35 (7.8) | 55.3 | 6 (12) | ||||
| Malignant | |||||||||||
| SCC | 108 (6) | 66 | 146 (81): 35 (19) | Limbal | 112(25.1) | 58.63 | 10(20) | >65 | 12:2 | Bulbar and limbal | |
| CIN (OSSN) | 71 (4) | 25(5.6) | 54.1 | 4(8) | |||||||
| Actinic keratosis | - | 17(3.8) | 50.12 | - | |||||||
| BCC | 2 (<1) | - | - | - | |||||||
| Mucoepidermoid carcinoma | - | 1(0.2) | 65 | ||||||||
| Melaocytic (total) | 872 (53) | 45 | 394 (45): 478 (55) | Limbal | 173(38.7) | 22.3 | 6 (12) | Bulbar and limbal | |||
| Nevus | 454 (52) | 10 (2.2) | 40.5 | Two cases | |||||||
| PAM | 180 (21) | 18 (4) | 59.39 | One case | |||||||
| MM | 215 (25) | 1 (0.2) | 29 | Three cases | |||||||
| Secondary acquired melanosis | - | ||||||||||
| Vascular (total) | 63 (4) | 39 | 36 (57): 27 (43) | Bulbar | 23 (5.1) | 22.26 | 2 (4) | Palpebraland bulbar | |||
| Pyogenic granuloma | 11 (1) | ||||||||||
| Hemangiomas | 52 (3) | ||||||||||
| Cystic | 27 (1) | 3 (6) | |||||||||
| Fibrous | 7 (<1) | 39 | 4 (57): 3 (43) | Bulbarand limbal | 2 (0.4) | 59 | |||||
| Neural | 1 (<1%) | 49 | 1 (100): 0 (0) | Limbal | 1 (0.2) | 3 | - | ||||
| Xanthoma | 1 (<1%) | 6 | 1 (100): 0 (0%) | Limbal | 1 (0.2) | 3 | - | ||||
| Myxomatous | 1 (<1%) | 29 | 0 (0): 1 (100) | Bulbar | - | - | - | ||||
| Lipomatous (total) | 23 (<1%) | 61 | 13 (57): 10 (43) | Bulbar | - | - | - | ||||
| Herniated orbital fat | 20 (<1) | ||||||||||
| Lacrimal gland | 12 (<1%) | 57 | 6 (50): 6 (50) | Fornix | - | - | - | ||||
| Lymphoid (total) | 128 (8%) | 57 | 64 (50): 64 (50) | Fornix | 3 (0.7) | 72 | 3 (6) | Bulbar and fornix and diffuse | |||
| Lymphoma | Two cases | ||||||||||
| BLH | One case | ||||||||||
| Leukemic | 3 (<1%) | 72 | 1 (33): 2 (67) | Equal limbal, bulbar, palpebral | - | - | - | ||||
| Metastatic | 13 (<1%) | 54 | 7 (54): 6 (46) | Bulbar | - | ||||||
| Secondary | 54 (3%) | 64 | 22 (41): 32 (59) | Bulbar | - | ||||||
| Degenerative and inflammatory simulating tumors | 179 (12%) | 48 | 102 (50): 104 (50) | Bulbar | 16 (32) | Bulbar | |||||
| Total | 1643 | 842:801 | 447 | 38.7 | 270:177 | 50 | 34:16 | ||||
Age is expressed as mean M:F;male:female
Site represents the commonest site of affection
SCC - Squamous cell carcinoma; CIN - conjunctival intraepithelial neoplasia or OSSN; BCC - Basal cell carcinoma; MM - Malignant melanoma; BLH - benign lymphoid hyperplasia